Sona Nanotech, Inc (TSE:SONA) has released an update.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Sona Nanotech, Inc. has secured a total of $40,000 in grant funding to enhance its intellectual property portfolio, with contributions from the NRC IRAP and Springboard Atlantic programs. The funds will aid in developing a robust IP strategy and the finalization of a provisional patent for a novel cancer drug delivery concept. The company’s CEO, David Regan, acknowledges the importance of this support for advancing their proprietary gold nanorod technology in cancer research and development.
For further insights into TSE:SONA stock, check out TipRanks’ Stock Analysis page.
